Rare Disease Report

Ataluren - the meta-analysis

JULY 08, 2016
Craig Campbell, MD



Dr Craig Campbell of the Department of Pediatric Neurology at Western University talks about the meta-analysis performed on the two phase 3 studies involving ataluren to treat children with Duchenne muscular dystrophy.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.